The Compound Testing (Scout Program) by the International Rett Syndrome Foundation speeds up preclinical testing of potential Rett syndrome treatments using a specialized mouse model.
Rett Syndrome Research Trust funds innovative, year-round research proposals to advance understanding and treatment of Rett syndrome through basic, translational, or clinical science.
The COE Clinical Research Awards from the International Rett Syndrome Foundation fund clinical research at Centers of Excellence to advance treatments and potential cures for Rett syndrome.
The Research Initiative Program by NTSAD funds research to advance understanding and treatment of Tay-Sachs, Canavan, GM1, and Sandhoff diseases through innovative science and collaboration.
The CURE SYNGAP1 Grants Program funds research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.
The Lawrence and Isabel Barnett Drug Development Program supports academic and industry investigators conducting preclinical studies of new or repurposed ALS therapies to advance them toward clinical testing.